LRWA
Long Run Wealth Advisors’s Pfizer PFE Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $1.57M | Buy |
64,645
+6,409
| +11% | +$155K | 0.33% | 52 |
|
|
2025
Q1 | $1.48M | Buy |
58,236
+6,235
| +12% | +$158K | 0.33% | 52 |
|
|
2024
Q4 | $1.38M | Buy |
52,001
+5,916
| +13% | +$157K | 0.33% | 52 |
|
|
2024
Q3 | $1.33M | Buy |
46,085
+6,121
| +15% | +$177K | 0.31% | 57 |
|
|
2024
Q2 | $1.12M | Buy |
39,964
+3,072
| +8% | +$86K | 0.28% | 62 |
|
|
2024
Q1 | $1.02M | Buy |
36,892
+3,025
| +9% | +$83.9K | 0.27% | 63 |
|
|
2023
Q4 | $975K | Buy |
33,867
+1,557
| +5% | +$44.8K | 0.28% | 62 |
|
|
2023
Q3 | $1.07M | Buy |
32,310
+1,328
| +4% | +$44.1K | 0.35% | 54 |
|
|
2023
Q2 | $1.14M | Buy |
30,982
+1,023
| +3% | +$37.5K | 0.36% | 57 |
|
|
2023
Q1 | $1.22M | Buy |
29,959
+1,541
| +5% | +$62.9K | 0.42% | 55 |
|
|
2022
Q4 | $1.46M | Sell |
28,418
-660
| -2% | -$33.8K | 0.52% | 47 |
|
|
2022
Q3 | $1.27M | Buy |
29,078
+4,851
| +20% | +$212K | 0.5% | 46 |
|
|
2022
Q2 | $1.27M | Sell |
24,227
-143
| -0.6% | -$7.5K | 0.49% | 45 |
|
|
2022
Q1 | $1.26M | Sell |
24,370
-1,091
| -4% | -$56.6K | 0.44% | 49 |
|
|
2021
Q4 | $1.5M | Buy |
+25,461
| New | +$1.5M | 0.52% | 45 |
|